An ad hoc committee, under the auspices of the National Academies of Sciences, Engineering, and Medicine's Health and Medicine Division, has been convened to study temporomandibular disorders (TMD) in a project entitled From Research Discoveries to Clinical Treatment.

Temporomandibular disorders (TMD) are the leading cause of chronic orofacial pain. They represent a type of "idiopathic" pain disorder, meaning that the cause or causes are unknown, but research over the decade suggests a genetic component contributing to susceptibility.

The first meeting of the National Academy of Medicine Committee on Temporomandibular Disorders (TMD): From Research Discoveries to Clinical Treatment will be held Tuesday, January 29, 2019 at the National Academy of Sciences building in Washington, D.C.&

The Trial of the Class Action brought by Canadian patients who were implanted with Vitek Proplast TMJ implants, against Health Canada, alleging negligent regulation starts on April 1, 2019 in Toronto.

ACTIVITIES AND PROGRAMS

Jun 18, 2014

The TMJ Association (TMJA) continues to strive for its ultimate goal: the development of universal standards for safe, effective, affordable, science-based diagnostics, treatments, and prevention of temporomandibular disorders (TMD). We understand that patient education, advocacy, and the provision of accessible support systems are central to achieving that goal.

The TMJA serves patients, professionals, and the general public through a variety of educational, social, and advocacy programs.

We represent the needs of patients by participating in government health care policy and research meetings, testifying before congressional committees, and working to promote temporomandibular joint research and development activities in all relevant government agencies. We recognize that educating elected officials is essential to directing attention to the prevalence, cost, and long-term pain and disability often associated with these complex disorders.

The TMJ Association continues to strive for its ultimate goal: the development of universal standards for safe, effective, affordable, science-based diagnostics, treatments, and prevention of temporomandibular disorders (TMJDs). We understand that patient education, advocacy, and the provision of accessible support systems are central to achieving that goal.

The TMJA serves patients, professionals, and the general public through a variety of educational, social, and advocacy programs:

We represent the needs of patients by participating in government health care policy and research meetings, testifying before congressional committees, and working to promote temporomandibular joint research and development activities in all relevant government agencies. We recognize that educating elected officials is essential to directing attention to the prevalence, cost, and long-term pain and disability often associated with these complex disorders.

This website is for general informational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. This website is not a substitute for such advice, diagnosis, or treatment. You should always consult your doctor if you have questions about your health condition or before starting any treatment. The TMJA is unable to provide doctor referrals and does not endorse any particular health care professional or organization. Reliance on any information provided by the TMJA, TMJA employees, other personss appearing on the website at the invitation of the TMJA, or other visitors to the website is solely at your own risk.